Total Payments
$364.24
2024 Payments
$77.09
Companies
2
Transactions
13
Medicare Patients
923
Medicare Billing
$223,980
Payment Breakdown by Category
Food & Beverage$364.24 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $364.24 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $198.36 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $165.88 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77.09 | 3 | AstraZeneca Pharmaceuticals LP ($48.20) |
| 2023 | $21.74 | 1 | AstraZeneca Pharmaceuticals LP ($21.74) |
| 2022 | $131.39 | 2 | GlaxoSmithKline, LLC. ($108.36) |
| 2021 | $16.00 | 1 | AstraZeneca Pharmaceuticals LP ($16.00) |
| 2020 | $35.32 | 2 | AstraZeneca Pharmaceuticals LP ($35.32) |
| 2019 | $69.71 | 3 | AstraZeneca Pharmaceuticals LP ($41.08) |
| 2018 | $12.99 | 1 | AstraZeneca Pharmaceuticals LP ($12.99) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Respiratory | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Respiratory | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Respiratory | ||||||
| 12/13/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $108.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Respiratory | ||||||
| 03/05/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 11/24/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Respiratory | ||||||
| 03/04/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Respiratory | ||||||
| 11/13/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Respiratory | ||||||
| 04/16/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Respiratory | ||||||
| 09/07/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 184 | 421 | $153,397 | $47,532 |
| 2022 | 9 | 281 | 544 | $200,927 | $61,648 |
| 2021 | 7 | 208 | 436 | $159,319 | $51,031 |
| 2020 | 8 | 250 | 507 | $195,823 | $63,770 |
Total Patients
923
Total Services
1,908
Medicare Billing
$223,980
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 159 | $54,529 | $17,164 | 31.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 82 | $51,496 | $16,065 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 99 | $22,365 | $7,083 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 25 | 35 | $9,955 | $2,697 | 27.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 13 | 14 | $5,460 | $1,712 | 31.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $5,368 | $1,555 | 29.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 18 | $4,224 | $1,257 | 29.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 45 | 141 | $92,919 | $29,047 | 31.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 114 | $34,314 | $10,732 | 31.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 102 | $21,420 | $6,741 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 53 | 80 | $23,120 | $6,569 | 28.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 12 | $7,020 | $2,133 | 30.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $5,628 | $1,772 | 31.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 12 | 13 | $5,239 | $1,655 | 31.6% |
| 94004 | Nursing facility ventilation assistance and management | Facility | 2022 | 16 | 47 | $6,815 | $1,592 | 23.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 21 | 21 | $4,452 | $1,406 | 31.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 42 | 105 | $68,046 | $21,843 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 68 | 175 | $51,086 | $16,966 | 33.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 33 | 51 | $15,008 | $4,379 | 29.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $8,246 | $2,476 | 30.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 36 | $7,632 | $2,395 | 31.4% |
| 94004 | Ventilation assistance and management, nursing facility per day | Facility | 2021 | 11 | 34 | $4,828 | $1,541 | 31.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 21 | 21 | $4,473 | $1,429 | 32.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 51 | 139 | $89,762 | $29,619 | 33.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 72 | 199 | $59,181 | $19,481 | 32.9% |
About Trupti Vakde
Trupti Vakde is a Pulmonary Disease healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1013241173.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Trupti Vakde has received a total of $364.24 in payments from pharmaceutical and medical device companies, with $77.09 received in 2024. These payments were reported across 13 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($364.24).
As a Medicare-enrolled provider, Vakde has provided services to 923 Medicare beneficiaries, totaling 1,908 services with total Medicare billing of $223,980. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Bronx, NY
- Active Since 09/22/2009
- Last Updated 04/29/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013241173
Products in Payments
- NUCALA (Biological) $165.88
- FASENRA (Drug) $70.33
- FASENRA (Biological) $60.77
- AIRSUPRA (Drug) $48.20
- BEVESPI AEROSPHERE (Drug) $19.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Bronx
Dr. Raji Ayinla, M.d, M.D
Pulmonary Disease — Payments: $699,684
Pulmonary Disease $699,684
Peter Dicpinigaitis, Md, MD
Pulmonary Disease — Payments: $305,607
Pulmonary Disease $305,607
Neomi Shah, M.d, M.D
Pulmonary Disease — Payments: $16,397
Pulmonary Disease $16,397
Richard Deluca, M.d, M.D
Pulmonary Disease — Payments: $14,463
Pulmonary Disease $14,463
Dr. Samuel Deleon, M.d, M.D
Pulmonary Disease — Payments: $11,703
Pulmonary Disease $11,703
Dr. Manuel Cabrera, Md, MD
Pulmonary Disease — Payments: $7,790
Pulmonary Disease $7,790